Mana.bio

Programmable Drug Delivery

San Francisco, United States · Founded 2021 · $19.5M raised

Employees
11–50
Founded
2021
Business Model
B2B
Website
mana.bio
Total Funding
$19.5M
Last Round
$19.5M SeedOct 2023
Rounds
1

About

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines. The company uses machine learning and nanotechnology to identify formulations of lipid nanoparticle drug delivery systems. Mana introduces Mina, the first AI Agent built specifically for lipid nanoparticles, helping scientists, formulation experts, and biotech teams explore curated literature, predict LNP properties, and optimize formulations. Mana is founded and led by a team of repeat entrepreneurs and experts in drug delivery, machine learning and software development.

Summary

Mana.bio is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. It has raised $19.5M in total across 1 round, most recently a $19.5M Seed round in Oct 2023.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedOct 2023
$19.5M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mana.bio on Indexed.vc
<a href="https://indexed.vc/companies/mana-bio"><img src="https://indexed.vc/api/badge/company/mana-bio" alt="Mana.bio on Indexed.vc" width="260" height="76" /></a>